The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts

This publication has 28 references indexed in Scilit:

• Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.
  Circulation, 1994
• Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)
  Annals of Internal Medicine, 1993
• Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
  The Lancet, 1992
• Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
  JAMA, 1990
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Can lifestyle changes reverse coronary heart disease?: The Lifestyle Heart Trial
  Published by Elsevier ,1990
• Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
• The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native Circulation
  New England Journal of Medicine, 1984
• Aortocoronary bypass saphenous vein graft atherosclerosis: Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively
  The American Journal of Cardiology, 1977
• Pathological Changes in Surgically Removed Aortocoronary Vein Grafts
  The Annals of Thoracic Surgery, 1976